Skip to main content

Table 4 Interleukin IL-10 mean plasma concentrations in controls and OC patients according to gene polymorphism (1082 G/A and 819 C/T)

From: Gene polymorphisms of interleukin 10 (− 819 C/T and − 1082 G/A) in women with ovarian cancer

Genotype

Control

Ovarian cancer

P value

(N = 48)

(N = 48)

(Mean ± SE)

(Mean ± SE)

IL-10 (− 819 C/T) (pg/ml) (N)

C/C (20, 3)

33.07 ± 2.60

38.40 ± 3.98

NS

C/T (24, 34)

35.22 ± 1.95

51.98 ± 3.32

P < 0.001

T/T (4, 11)

34.15 ± 5.02

43.41 ± 4.00

NS

C (44,37)

34.24 ± 1.58

50.88 ± 3.12

P < 0.001

T(28,45)

35.06 ± 1.78

49.88 ± 2.73

P < 0.001

IL-10 (− 1082 G/A) (pg/ml) (N)

G/G (8, 16)

38.02 ± 2.26

45.42 ± 3.12

NS

G/A (27, 28)

33.48 ± 2.24

50.27 ± 3.95

P < 0.001

A/A (13, 4)

32.78 ± 2.50

56.40 ± 7.21

P < 0.05

G (35,44)

34.52 ± 1.82

48.51 ± 2.75

P < 0.001

A (40,32)

33.25 ± 1.70

51.04 ± 3.55

P < 0.001

Haplotype

GC (34,14)

39.16 ± 3.07

50.40 ± 5.56

NS

AC (36,25)

33.15 ± 1.82

53.58 ± 4.22

P < 0.001

AT (27,30)

34.67 ± 1.80

52.11 ± 3.71

P < 0.001

GT (18,41)

36.40 ± 2.22

49.25 ± 2.91

P < 0.01

  1. *P < 0.05, **P < 0.01 and ***P < 0.001
  2. Data are reported as mean ± SE. Data were analyzed using Student’s t test
  3. SE standard error